LIQUIDITY ALERT: Synovics Pharmaceuticals Current Deficit Up 16%
Synovics Pharmaceuticals, Inc.,’s working capital deficit rose by 63.2%, from US$6,335,161 at Oct. 31, 2008 to US$10.337.159 at April 30, 2009.
The Company reported US$5,134,320 in current assets and US$15,471,479 in…